Ultragenyx Pharmaceutical Inc.

8-K Director or officer change; Shareholder vote results May 18, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Other events Apr 2, 2026 8-K Other events Mar 30, 2026 8-K Other events Mar 12, 2026 8-K Other events Feb 23, 2026 10-K Fiscal year ended 2025-12-31 Feb 18, 2026 8-K Results of operations (earnings release); Exit or disposal costs Feb 12, 2026 8-K Other events Feb 3, 2026 8-K Other events Jan 30, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Other events Dec 30, 2025 8-K Other events Dec 29, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Entered a material agreement; Results of operations (earnings release) Nov 4, 2025 8-K Other events Oct 30, 2025 8-K Other events Sep 8, 2025 8-K Other events Aug 18, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Other events Jul 31, 2025 8-K Other events Jul 11, 2025 8-K Other events Jul 9, 2025 8-K Other events Jun 27, 2025 8-K Director or officer change; Shareholder vote results May 19, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Feb 19, 2025 8-K Results of operations (earnings release) Feb 13, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K Other events Dec 19, 2024 8-K Other events Dec 19, 2024 8-K Other events Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 5, 2024 8-K Other events Oct 7, 2024 8-K Other events Oct 3, 2024 10-Q Quarter ended 2024-06-30 Aug 2, 2024 8-K Results of operations (earnings release) Aug 1, 2024